View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Sanofi Mature IPOperating co.
- Sanofi Winthrop IndustrieOperating co.
- Sanofi-Aventis GmbHOperating co.
- Sanofi BelgiumOperating co.
- Sanofi-Aventis Deutschland GmbHOperating co.
- Sanofi S.r.l.Operating co.
- Sanofi B.V.Operating co.
- Sanofi - Produtos Farmaceuticos LdaOperating co.
- Sanofi ABOperating co.
- Sanofi A/SOperating co.
Representatives- Frédéric Chevallier-Herbert Smith Freehills Kramer LLP
Respondents- Accord Healthcare S.L.U.Operating co.
- Accord Healthcare GmbH (AT)Operating co.
- Accord Healthcare B.V.Operating co.
- Accord Healthcare GmbH (DE)Operating co.
- Accord Healthcare Italia SrlOperating co.
- Accord Healthcare, Unipessoal Lda.Operating co.
- Accord Healthcare ABOperating co.
- STADAPHARM GmbHOperating co.
- STADA Arzneimittel AGOperating co.
- STADA Nordic ApSOperating co.
- Reddy Pharma SASOperating co.
- betapharm Arzneimittel GmbHOperating co.
- Dr Reddy's SrlOperating co.
- Zentiva FranceOperating co.
- Zentiva Pharma GmbHOperating co.
- Zentiva, k.s.Operating co.
Representatives- Jules Fabre-Pinsent Masons
- Arjan Reijns-Pinsent Masons
- Louise Millot-Pinsent Masons
- Daniel Hoppe-Bonabry
- Christian Meyer-Maiwald
- Andreas Ledl-Maiwald
- Anja Lunze-Taylor Wessing
- Elisabeth Greiner-df-mp
- Division
- Munich LD
- Judges
- Technology
- ChemistryPharmaceuticals
- Language
- —
- First decided
- Jan 17, 2025
- EPO Opposition
- Glenmark Pharmaceuticals Europe Ltd2021-03-10
- Accord Healthcare LtdAdmissible2021-03-10
- Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
- EVER Valinject GmbHWithdrawn2021-03-12
- Zentiva k.s.Admissible2021-03-12
- medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
- Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
- Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
- Betapharm Arzneimittel GmbHAdmissible2021-03-31
- Generics (U.K.) LimitedAdmissible2021-06-08
- Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
- STADA Arzneimittel AGAdmissible2021-12-09
- Maiwald GmbHAdmissible2021-12-10
- Accord Healthcare S.L.U.2024-08-30
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
At the UPC: Sanofi Group (33 cases)·Accord Group (8 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 24 other proceedings
UPC CoA 22/2026·UPC CoA 23/2026·UPC CoA 24/2026·UPC CoA 25/2026·UPC CoA 26/2026 and 19 more
Decisions
- 2025-01-17Application RoP305Public
Summary: The Munich Local Division issued a procedural order in multiple related infringement actions by Sanofi against various generic manufacturers (Accord, STADA, Dr. Reddy's, Zentiva) concerning EP 2 493 466. The order addressed the substitution of Sanofi Mature IP by Sanofi SA as new patent proprietor following Sanofi Mature IP's dissolution, and the consequential procedural steps under R. 310 RoP.
Show the legal issues (3)
- Change of party: substitution of patent proprietor following dissolution (R. 310 RoP)
- R. 305 RoP application
- Multi-case pharmaceutical patent infringement proceedings
Documents
- 65DD6F8DBE3E1F014557C5F4AFC6E4B9_en.pdf2025-01-17EN